SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899866-19-000048
Filing Date
2019-03-05
Accepted
2019-03-05 20:18:07
Documents
1
Period of Report
2019-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_155183507279607.html 4  
1 FORM 4 wf-form4_155183507279607.xml 4 3326
  Complete submission text file 0000899866-19-000048.txt   4782
Mailing Address 121 SEAPORT BOULEVARD BOSTON MA 02210
Business Address 121 SEAPORT BOULEVARD BOSTON MA 02210 4752302596
ALEXION PHARMACEUTICALS, INC. (Issuer) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BAXALTA INCORPORATED 1200 LAKESIDE DRIVE BANNOCKBURN IL 60015
Business Address
ORLOFF JOHN J (Reporting) CIK: 0001643941 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-27756 | Film No.: 19660900